Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. egypt
  4. solid tumor
Show results for
Products
Services
Software
Applications

Companies


Refine by
Locations
Back to All Locations

  • Africa
  • Egypt
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
Industries served

  • Medical / Health Care
  • Monitoring and Testing
  • Chemical & Pharmaceuticals
  • Environmental
Employees

  • Over 1000
  • 101-1000

Solid Tumor Suppliers Serving Egypt

55 companies found
Serving EgyptNear Egypt

Celularity Inc.

Celularity Inc.

based inFlorham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
Celularity - Model CAR-T - Chimeric Antigen Receptor T Cells

Celularity - Model CAR-T - Chimeric Antigen Receptor T Cells

Chimeric Antigen Receptor T cells (CAR-T) are genetically engineered T cells that are modified to express an artificial T cell receptor on their surface that binds and targets cancer proteins in an HLA-independent ...
CONTACT SUPPLIER

NeoTherma Oncology

NeoTherma Oncology

based inWichita, KANSAS (USA)
Neotherma Oncology is led by experienced healthcare executives who are working toward the dream of more effective treatments for cancer. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treatment for deep solid ...
NeoTherma VectRx - Clinical Stage Medical Device

NeoTherma VectRx - Clinical Stage Medical Device

NeoTherma Oncology is a clinical stage medical device company developing a proprietary Thermal Treatment (VectRx) system for deep solid tumors. Our technology is based on applying a safe, non-invasive, non-ionizing ...
CONTACT SUPPLIER

Lucence Health Inc.

Lucence Health Inc.

based inPalo Alto, CALIFORNIA (USA)
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and ...
Lucence Tissue500 - Comprehensive Genomic Profiling Test

Lucence Tissue500 - Comprehensive Genomic Profiling Test

Tissue500™ is a comprehensive genomic profiling test that detects clinically relevant mutations in 572 genes to identify a patient’s unique cancer ...
CONTACT SUPPLIER

Antengene Corporation Limited

Antengene Corporation Limited

based inChangning District, CHINA
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative ...
CONTACT SUPPLIER

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics Ltd.

based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
CONTACT SUPPLIER

SystImmune Inc.

SystImmune Inc.

based inRedmond, WASHINGTON (USA)
SystImmune Inc. is a biopharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug conjugates (ADCs). Our objective is to create biologics that ...
SystImmune - Model GNC-039 - Guidance and Navigation Control (GNC) Molecules

SystImmune - Model GNC-039 - Guidance and Navigation Control (GNC) Molecules

Guidance and Navigation Control (GNC) molecules are multi-specific cell engager proteins. GNC in the oncology therapeutics class bind to cancer cells and to immune cells and stimulate the immune cell cancer killing activity. By design, each GNC ...
CONTACT SUPPLIER

AbelZeta Inc.

AbelZeta Inc.

based inRockville, MARYLAND (USA)
Since the treatment of our first oncology patient in 2015, AbelZeta has been able to build best-in-class and best-in-disease potential pipeline, leading to the licensing of two CD20-directed autologous CAR-Ts to Janssen Biotech in 2023. Our goal is ...
Model C-CAR031 - Solid Tumors

Model C-CAR031 - Solid Tumors

PRODUCT: C-CAR031. INDICATION: HCC. PLATFORM: CAR-T. PRECLINICAL: GPC3. IIT: -. PHASE 1/1B: -. PHASE 2: -. PARTNERS: ...
CONTACT SUPPLIER

HEALIOS K.K.

HEALIOS K.K.

based inTokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
iPS Cell-Derived Gene-Edited NK Cells and Cancer Immuno-oncology

iPS Cell-Derived Gene-Edited NK Cells and Cancer Immuno-oncology

Cancer is the leading cause of death in Japan, with approximately 90% of those deaths said to be caused by solid ...
CONTACT SUPPLIER

Boston Pharmaceuticals

Boston Pharmaceuticals

based inCambridge, MASSACHUSETTS (USA)
We are a group of individuals who know that there is a better way to develop drugs. Our business model and broad, science-based portfolio has attracted some of the brightest minds in drug development. Our team brings together more than 300 years of ...
Boston - Model BOS-371 - Potent Monoclonal Antibody

Boston - Model BOS-371 - Potent Monoclonal Antibody

BOS-371 is a highly potent monoclonal antibody targeting the Interleukin-1 Receptor Accessory Protein (IL1RAP), a prevalent tumor associated antigen driving tumor growth and immunosuppression. BOS-371 has also been Fc-engineered to enhance effector ...
CONTACT SUPPLIER

IMB Dx, Inc.

IMB Dx, Inc.

based inSeoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
AlphaLiquid - Model Detect - Tumor-Informed, Hybrid-Capture NGS-Based Liquid Biopsy Test

AlphaLiquid - Model Detect - Tumor-Informed, Hybrid-Capture NGS-Based Liquid Biopsy Test

AlphaLiquid® Detect is an industry-first tumor-informed, hybrid-capture NGS-based liquid biopsy test designed for MRD detection and recurrence monitoring in stage I-III solid tumor patients. The ...
CONTACT SUPPLIER

Caprico Biotechnologies, Inc. (CBI)

Caprico Biotechnologies, Inc. (CBI)

based inNorcross, GEORGIA (US) (USA)
Caprico Biotechnologies, Inc. (CBI) was founded in 2013 by a group of experienced scientists with broad clinical and basic research experience in chemistry, molecular biology, and immunology. We are committed to providing a range of flow cytometry ...
CONTACT SUPPLIER

Myeloid Therapeutics

Myeloid Therapeutics

based inCambridge, MASSACHUSETTS (USA)
Myeloid Therapeutics is a leader in the development of mRNA-based immunotherapies, focusing on harnessing and enhancing the natural capabilities of myeloid cells to combat cancer. The company's cutting-edge in vivo engineering platform is designed ...
mRNA Cell Therapy Technology

mRNA Cell Therapy Technology

Myeloid is focused on advancing its ATAK CAR monocytes, which are myeloid cells with innate immune receptor-inspired CARs to recognize and kill cancer. Additionally, Myeloid has streamlined manufacturing for its ATAK cell therapy candidates through ...
CONTACT SUPPLIER

Kailos Genetics, LLC.

Kailos Genetics, LLC.

based inHuntsville, ALABAMA (USA)
Kailos Genetics provides consumers access to affordable physician-ordered genetic tests. It is our mission to help people take control of their health and make more informed decisions. The Kailos test is an easily accessible genetic test catered to ...
Kailos Iota - Liquid Biopsy Technology

Kailos Iota - Liquid Biopsy Technology

Kailos Iota combines TargetRich, our foundational genetic enrichment technology, with next-generation sequencing and statistical machine learning that results in a highly specific cancer assay of multiple solid ...
CONTACT SUPPLIER

PharmAbcine Inc.

PharmAbcine Inc.

based inYuseong-gu, SOUTH KOREA
We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs. We have been committed to developing novel antibody therapeutics since ...
PharmAbcine - Model PMC-403 - Monoclonal Antibody

PharmAbcine - Model PMC-403 - Monoclonal Antibody

PMC-403 is a monoclonal antibody that targets the human TIE2 that regulate the angiogenesis and vessel maturation in endothelial cells. It binds to TIE2 expressing endothelial cells and normalize VEGF-induced pathological leaky blood vessels in eyes ...
CONTACT SUPPLIER

Sequoia Vaccines, Inc.

Sequoia Vaccines, Inc.

based inSaint Louis, MISSOURI (USA)
Sequoia Vaccines is a clinical stage pharmaceutical company discovering and developing new vaccines preventing bacterial infections and medicines treating cancers and bacterial infections. Sequoia’s lead clinical candidate is a vaccine for the ...
Sequoia - Model SQ1274 - Anticancer Compound

Sequoia - Model SQ1274 - Anticancer Compound

Sequoia is developing an anticancer compound (SQ1274) for use against solid tumors including ovarian and lung ...
CONTACT SUPPLIER

ITM Isotope Technologies Munich SE

ITM Isotope Technologies Munich SE

based inGarching / Munich, GERMANY
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes ...
CONTACT SUPPLIER

Elicio Therapeutics

Elicio Therapeutics

based inBoston, MASSACHUSETTS (USA)
We harness the natural power of the lymph nodes to generate enhanced immune responses against tumors. Our science is defining the future of immunotherapy, with the goal of giving patients who are battling cancer their best possible outcome. We’re ...
Elicio - Model ELI-008 - Multivalent Lymph Node–Targeted AMP Peptide Vaccine

Elicio - Model ELI-008 - Multivalent Lymph Node–Targeted AMP Peptide Vaccine

ELI-008 is a multivalent lymph node–targeted AMP peptide vaccine developed to target p53 hotspot mutations. p53 is a tumor-suppressing protein that controls the cell cycle, DNA replication, and uncontrolled ...
CONTACT SUPPLIER

Oxford Gene Technology IP Limited

Oxford Gene Technology IP Limited

based inOxford, UNITED KINGDOM
As a leading global provider of diagnostic genomic solutions, our goal is to enable researchers and clinical decision makers to reach the right decisions for each patient, every time. The quality and innovation built into our products for NGS, ...
CytoCell - Model HER2 (ERBB2) - Amplification Solid Tumour Probes

CytoCell - Model HER2 (ERBB2) - Amplification Solid Tumour Probes

The HER2 amplification probe consists of a 347kb probe labelled in red, spanning the HER2 (ERBB2) gene and neighbouring regions, and a green probe for the chromosome 17 ...
CONTACT SUPPLIER

Transgene

Transgene

based inIllkirch-Graffenstaden, FRANCE
Transgene is a clinical-stage biotechnology company focused on designing and developing novel immunotherapeutics. Every day, we push the boundaries of innovation with our therapeutic vaccines and oncolytic viruses, to design better treatments for ...
Transgene - Model TG6002 - Oncolytic Virus

Transgene - Model TG6002 - Oncolytic Virus

A new generation of multifunctional oncolytic virus, TG6002 has been designed to combine the mechanism of oncolysis (targeted destruction of the cancer cell) with the production of chemotherapy (5-FU), directly into the ...
CONTACT SUPPLIER

Immatics N.V.

Immatics N.V.

based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
ACTengine - Next-generation Enhancement Strategies

ACTengine - Next-generation Enhancement Strategies

Immatics’ latest proprietary ACTengine® manufacturing processes are designed to generate cell product candidates within a short manufacturing window and deliver highly proliferative T cells, with the capability to infiltrate the ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT